Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease

Researchers find 9 cannabinoids that might protect the brain against toxicities associated with aging. These non-intoxicating cannabinoids are potential drug candidates for Alzheimer’s Disease, and they might also be options for other neurodegenerative diseases, too

View this review (yellow link) or download:

This paper is also stored here:     http://bit.ly/2L9GccX    inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDEfficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease

Related Posts